CKD and Diabetes: How to Manage Both at the Same Time

Diabetes is the leading cause of chronic kidney disease (CKD) in the United States, responsible for roughly 40% of all kidney failure cases, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). When CKD and diabetes occur together — a condition called diabetic nephropathy or diabetic kidney disease (DKD) — each disease speeds up the other. Managing both at the same time means coordinating blood sugar control, blood pressure control, diet, and kidney function monitoring, usually with a care team that includes a nephrologist, endocrinologist, and renal dietitian.

This guide breaks down what diabetic kidney disease is, which medications are safe, what your targets should be, and how your diet needs to change. As always, this content is educational and does not replace advice from your physician or care team.

What Is Diabetic Nephropathy?

Diabetic nephropathy is damage to the small blood vessels (glomeruli) inside your kidneys, caused by years of high blood glucose. It is the clinical name for kidney disease that develops because of diabetes, and it is also called diabetic kidney disease (DKD).

How does diabetic nephropathy progress?

Diabetic nephropathy typically develops in a predictable sequence:

• Microalbuminuria — the earliest detectable sign, where small amounts of protein (albumin) leak into the urine. This is measured using the urine albumin-to-creatinine ratio (uACR), with microalbuminuria defined as a uACR between 30–300 mg/g.
• Macroalbuminuria — larger amounts of protein leak into the urine, with uACR rising above 300 mg/g.
• Declining eGFR — kidney filtering ability (estimated glomerular filtration rate) begins to drop measurably.
• Kidney failure — in advanced cases, eGFR falls low enough to require dialysis or transplant.

Why does high blood sugar damage the kidneys?

Sustained high blood glucose injures the glomeruli, the tiny filtering units inside each kidney. Over years, this damage lets protein leak into urine and gradually reduces the kidneys' ability to filter waste. HbA1c — a blood test that reflects average blood sugar over about three months — is the standard way doctors track this risk over time.

What Blood Sugar Target Should CKD + Diabetes Patients Aim For?

Most adults with CKD and diabetes should aim for an HbA1c below 7.0%, according to the American Diabetes Association (ADA) 2024 Standards of Care. This target is individualized — some patients may have a slightly higher or lower goal depending on age, hypoglycemia risk, and other health conditions.

Why is HbA1c less reliable in advanced CKD?

In advanced CKD (stages 4–5), HbA1c results can become inaccurate because kidney disease alters how quickly red blood cells are made and replaced (red blood cell turnover). When red blood cell turnover changes, the HbA1c number may not reflect true average blood sugar. In these cases, doctors may use fructosamine, a different blood test that is less affected by red blood cell lifespan, as a more reliable marker.

Do diabetes medication doses need to change with CKD?

Yes. Several diabetes medications, including metformin, require dose adjustments or discontinuation as eGFR declines. Never adjust or stop a diabetes medication without your physician's guidance — stopping or changing doses on your own can cause dangerous blood sugar swings.

Which Diabetes Medications Are Safe With CKD?

The safety and dosing of diabetes medications depends heavily on your current eGFR. Here is how the major drug classes are generally used in CKD, according to clinical trial data — always confirm your specific regimen with your physician.

Are SGLT2 inhibitors safe for kidney disease?

Yes. SGLT2 inhibitors such as empagliflozin and dapagliflozin are both cardioprotective and nephroprotective. The CREDENCE trial and the DAPA-CKD trial both showed that SGLT2 inhibitors significantly slow the decline in kidney filtration (GFR) in people with CKD. These drugs are generally avoided or used with caution once eGFR falls below about 20–25, depending on the specific medication.

Are GLP-1 receptor agonists safe for kidney disease?

Generally, yes. GLP-1 receptor agonists such as semaglutide and liraglutide are generally considered safe in CKD. They reduce cardiovascular risk and support weight loss, which benefits many people managing both diabetes and CKD.

Is metformin safe with CKD?

Metformin is safe to use when eGFR is 30 or higher. It should be held when eGFR drops below 30, and it is contraindicated (should not be used) when eGFR falls below 15, because of the risk of a rare but serious condition called lactic acidosis. Your doctor will monitor your eGFR regularly to decide when metformin dosing needs to change.

Does insulin dosing change with CKD?

Yes. Insulin requires dose reduction as eGFR declines, because failing kidneys clear insulin from the body more slowly. This means the same insulin dose can last longer and act more strongly in someone with reduced kidney function, raising the risk of low blood sugar (hypoglycemia) if doses are not adjusted.

What Blood Pressure Target Applies When You Have Both CKD and Diabetes?

The blood pressure target for most people with both CKD and diabetes is below 130/80 mmHg, according to the ADA 2024 Standards of Care and KDOQI 2020 guidelines.

Which blood pressure medications are best for CKD and diabetes?

ACE inhibitors or ARBs (angiotensin receptor blockers) are the first-line treatment. These medications work by blocking the renin-angiotensin system, and they do double duty: they lower blood pressure while also directly reducing protein leakage (proteinuria) and protecting the kidneys. The RENAAL trial and the IDNT trial both demonstrated that ACE inhibitors and ARBs slow the progression of diabetic kidney disease beyond what blood pressure control alone would predict.

How Does Diet Change When You Have Both CKD and Diabetes?

A standard diabetic diet and a standard CKD diet often pull in opposite directions. This is one of the hardest parts of managing both conditions.

Why do diabetes and CKD diets conflict?

Many foods recommended for diabetes — like high-fiber fruits and vegetables — are also high in potassium and phosphorus, which need to be limited in CKD. A diet built only around blood sugar control can accidentally overload the kidneys with minerals they can no longer clear efficiently.

How much protein should someone with CKD and diabetes eat?

For non-dialysis CKD, the recommended protein target is 0.6–0.8 g/kg of body weight per day, according to KDOQI 2020 nutrition guidelines. This is lower than the protein intake typically recommended in a general diabetes diet, so portion adjustments are usually necessary.

How should carbohydrates be managed?

Choose low-glycemic carbohydrates that are also low in phosphorus and potassium. This helps control blood sugar spikes without adding extra mineral burden on the kidneys. A renal dietitian can help identify foods that satisfy both goals at once.

How much sodium is recommended?

Sodium intake should stay under 2,300 mg per day, according to the National Kidney Foundation (NKF). Lower sodium supports blood pressure control, which protects the kidneys further.

What is the Keto Nephron™ DS (NephLong) DKD Nutrition Challenge?

The Keto Nephron™ DS (NephLong) DKD Nutrition Challenge is a branded framework describing the four dietary targets that must be balanced at the same time in diabetic kidney disease:

• Blood sugar control — choosing low-glycemic carbohydrates
• Protein limits — staying within 0.6–0.8 g/kg/day for non-dialysis CKD
• Potassium and phosphorus limits — avoiding mineral overload from typical "diabetes-friendly" produce
• Sodium limits — staying under 2,300 mg/day to support blood pressure targets

Balancing all four simultaneously is difficult with diet alone, which is why many care teams bring in specialized nutrition support.

For patients with diabetic kidney disease in stages 3–5, some care teams use medical foods formulated for CKD's distinctive nutritional needs, under physician supervision. Keto Nephron™ DS (NephLong) is formulated for the dietary management of CKD stages 3–5, for use under physician supervision.

Ask your nephrologist and renal dietitian how to balance your diabetes diet with your CKD nutritional needs — and ask about medical foods like Keto Nephron™ DS (NephLong).

How Often Should CKD + Diabetes Patients Be Monitored?

Regular lab monitoring is essential because both diabetes and CKD can progress silently, without obvious symptoms, until significant damage has occurred.

What labs are needed and how often?

• HbA1c: every 3 months
• eGFR: every 3–6 months
• uACR: at least annually, or more frequently if levels are abnormal
• Potassium: every 3 months if taking an ACE inhibitor or ARB, since these medications can raise potassium levels

What is the Keto Nephron™ DS (NephLong) DKD Monitoring Schedule?

The Keto Nephron™ DS (NephLong) DKD Monitoring Schedule is a branded lab-tracking framework that organizes these four tests into a simple quarterly and annual rhythm, helping patients and caregivers know which test is due and when. Bringing a printed or digital tracker to each appointment can help ensure no test is missed.

Frequently Asked Questions

Can CKD caused by diabetes be reversed?

CKD caused by diabetes generally cannot be reversed once significant kidney damage has occurred, but its progression can often be slowed significantly with blood sugar control, blood pressure control, and appropriate medications like SGLT2 inhibitors and ACE inhibitors or ARBs.

What is the first sign of kidney damage from diabetes?

The first sign of kidney damage from diabetes is usually microalbuminuria, a small amount of protein (albumin) leaking into the urine, detected through a uACR test before symptoms appear.

Is metformin safe with CKD?

Metformin is safe when eGFR is 30 or higher, should be held when eGFR is below 30, and is contraindicated when eGFR falls below 15 due to the risk of lactic acidosis.

What blood sugar level damages kidneys?

Sustained high blood glucose, reflected by an HbA1c consistently above target range, damages the small blood vessels in the kidneys over time; the ADA 2024 Standards of Care recommend an HbA1c below 7.0% for most adults with diabetes and CKD to reduce this risk.

How fast does diabetic nephropathy progress?

The speed of diabetic nephropathy progression varies widely between individuals and depends on blood sugar control, blood pressure control, and genetic factors; some people progress from microalbuminuria to kidney failure over many years, while others progress much faster without treatment.

Sources & References

• NIDDK — Diabetic Kidney Disease
• NIDDK — Chapter 22: Kidney Disease in Diabetes, Diabetes in America 3rd Edition
• ADA/KDIGO 2022 Consensus Report — Diabetes Management in Chronic Kidney Disease
• KDOQI 2020 Clinical Practice Guideline for Nutrition in CKD
• NKF KDOQI Guidelines — Guideline 3: Management of Hypertension in Diabetes and CKD (RENAAL and IDNT trial data)